Introduction
Small-molecule and macromolecular crystal structures obtained at resolutions higher than 1.2 Å can be determined using direct methods. However, macromolecular structures are seldom obtained at such resolution, with less than 2% of the entries in the Protein Data Bank reported at 1.2 Å resolution or better. Structures at lower resolution are generally determined using either experimental phases (Adams et al., 2009 ) obtained using several different techniques [singlewavelength anomalous dispersion (SAD), multi-wavelength anomalous dispersion (MAD), single isomorphous replacement (SIR), multiple isomorphous replacement (MIR) and others] or molecular replacement (MR) with a homologous structure (generally >25-30% sequence identity and <1.5 Å C r.m.s.d. values; Rossmann, 1990; Scapin, 2013) .
For nucleic acids, a method has been reported for the de novo determination of novel, folded RNA structures using secondary-structure prediction and model A-form doublestranded RNA helices as search models in molecular replacement (Robertson et al., 2010; Robertson & Scott, 2008) . This technique has been successful in practical applications such as the crystal structures of the L1 ligase ribozyme ISSN 2053-230X # 2018 International Union of Crystallography (Robertson & Scott, 2007) and the preQ1 riboswitch (Klein et al., 2009) . In an analogous approach for proteins, the program ARCIMBOLDO can determine crystal structures ab initio via the generation of model polyalanine -helices and -strands in combination with molecular replacement (Rodríguez et al., 2009) . This program has been successful in several model and novel test cases (Rodríguez et al., 2009 (Rodríguez et al., , 2012 .
Crystal structures have recently been reported for several mycobacterial MeaB-and MMAA-like GTPases (Edwards et al., 2015) . Attempts to obtain a crystal structure of one of these proteins from Mycobacterium smegmatis (gene MSMEG_4869) resulted in crystals which diffracted to high resolution but with a unit cell that was far too small to contain the entire protein molecule. All attempts at molecular replacement failed and, owing to a limited number of crystals that were not reproducible, we were unable to obtain experimental phases. Ultimately, the phases were solved readily using ab initio structure determination in ARCIM-BOLDO with two model polyalanine -helices, which revealed the C-terminal dimerization domain of the intended target. Given the ease with which the structure could be determined, we present this as a model test case for crystallographers interested in sequence-independent structure determination using ARCIMBOLDO.
Materials and methods

Macromolecule production
The MSMEG_4869 gene from M. smegmatis encodes a 294-amino-acid protein (UniProt ID A0R1T8). The gene was cloned from genomic DNA into the pAVA0421 vector, which encodes an N-terminal hexahistidine affinity tag followed by the 3C protease cleavage sequence (Table 1) . The protein was expressed and purified following standard protocols described previously (Bryan et al., 2011; Choi et al., 2011; Serbzhinskiy et al., 2015) . Briefly, the plasmid was transformed into Escherichia coli BL21(DE3) R3 Rosetta competent cells and the protein was expressed using auto-induction medium (Studier, 2005) in a LEX Bioreactor (Epiphyte Three Inc.). The protein was purified by immobilized metal (Ni 2+ ) affinity chromato-graphy (IMAC), followed by cleavage of the expression tag with 3C protease, subtractive IMAC to remove the 3C protease and noncleaved protein, and size-exclusion chromatography (SEC) on a HiLoad 26/600 Superdex 75 (GE Healthcare) using a mobile phase consisting of 300 mM NaCl, 20 mM HEPES pH 7.0, 5% glycerol, 1 mM TCEP. The peak fractions were pooled and analysed by SDS-PAGE. The protein was concentrated to 60.56 mg ml À1 using an Amicon purification system (Millipore) and 200 ml aliquots were flashfrozen in liquid nitrogen and stored at À80 C until use in crystallization experiments. The protein was shown to be >95% pure by SDS-PAGE analysis. The SSGCID target identifier is MysmA.00200.a, the expression clone identifier is MysmA.00200.a.A1 and the protein batch identifier is MysmA.00200.a.A1.PS00535. The plasmid and the protein are available from SSGCID (http://www.ssgcid.org/ available-materials).
Crystallization
The protein at 60.56 mg ml À1 was crystallized using the sitting-drop vapor-diffusion method against the JCSG+ and PACT screens (Newman et al., 2005) . Initially, only poorly diffracting crystals were obtained. After four months, JCSG+ screen condition G7 yielded sizable crystals (Table 2) . Crystals were cryoprotected with 20%(v/v) ethylene glycol prior to vitrification in liquid nitrogen for X-ray data collection.
Data collection and processing
Data-collection and processing information is reported in Table 3 . The data were integrated with XDS and reduced with XSCALE (Kabsch, 2010) . The X-ray diffraction images were deposited with the Integrated Resource for Reproducibility in Macromolecular Crystallography and are available for PDB entry 6cum at https://www.proteindiffraction.org/ (Grabowski et al., 2016) .
Structure solution and refinement
The structure was determined de novo using ARCIM-BOLDO (Rodríguez et al., 2009) , followed by automated model building in ARP/wARP (Langer et al., 2008) . The structure was refined in PHENIX (Adams et al., 2010) with manual model building in Coot (Emsley & Cowtan, 2004) . The quality of the structure was assessed with MolProbity Table 1 Macromolecule-production information. 
Results and discussion
The Seattle Structural Genomics Center for Infectious Disease (SSGCID) is a structural genomics center funded by the National Institute of Allergy and Infectious Diseases (NIAID) with the mission to determine the crystal structures of potential drug targets from NIAID priority organisms (Myler et al., 2009; Stacy et al., 2011) . One of those organisms is M. tuberculosis (Mtb), the causative agent of tuberculosis. To maximize our chances of obtaining a structure of a specific target as well as our general understanding of the target, SSGCID has adopted an ortholog approach in which closely related species within the same genus are also targeted (Baugh et al., 2015; Edwards et al., 2012) . The Mtb target Rv1496 was originally misannotated as a lysine/arginine/ornithine transport system ATPase (LAO/AO ATPase), and was later shown to be an MeaB-and MMAA-like GTPase (Edwards et al., 2015) . (Edwards et al., 2015) . For the M. smegmatis ortholog from the MSMEG_4869 gene, we expressed and purified the 30.8 kDa recombinant protein to >95% purity as determined by SDS-PAGE analysis (data not shown). Crystals appeared after four months (Table 2 ). These crystals resulted in a 1.6 Å resolution data set in a trigonal point group (321) with unit-cell dimensions a = b = 48.53, c = 54.82 Å (Table 3) . Curiously, this unit cell can only accommodate approximately 8 kDa of protein mass, with a projected solvent content of 47%, whereas the target M. smegmatis protein from the MSMEG_4869 gene is approximately 30.8 kDa and cannot fit into the asymmetric unit. Therefore, we reduced the data in lower symmetry point groups (e.g. C2) to attempt structure determination via molecular replacement with Rv1496 or orthologs; this approach failed. We theorized that the crystals could contain the C-terminal dimerization domain (three -helices), yet attempts to solve the structure by MR using the C-terminal dimerization domains of Rv1496 or its orthologs also failed. This was not too surprising since the protein sequence from the MSMEG_4869 gene deviates significantly in its primary sequence for this region relative to orthologs (<20% sequence identity). Only a few crystals were obtained, and thus attempts to determine experimental phases using soaking experiments were limited to iodide ion soaking using a previously developed protocol (Abendroth et al., 2011) . This approach also failed, causing us to question whether these crystals were indeed the correct target or something else entirely. In addition to specific model-based molecular-replacement searches in Phaser (McCoy et al., 2007) and MOLREP (Vagin & Teplyakov, 2010) , PDB-wide molecular MR using MoRDa as well as sequence-independent MR using SIMBAD (Simpkin et al., 2018) , both of which are from the CCP4 suite (Winn et al., 2010) , also failed to produce a solution.
Use of the program ARCIMBOLDO has been described for ab initio structure determination using model polyalanine -helices and -strands for data sets below atomic resolution (Rodríguez et al., 2009 (Rodríguez et al., , 2012 novel protein (Rodríguez et al., 2009) , for DNA-binding proteins (Prö pper et al., 2014) and for coiled coils (Caballero et al., 2018) . Because this approach appears to work well at <2 Å resolution for proteins with a significant -helical content, it was applied to the 1.6 Å resolution data set. As a starting point, we searched for two helices with ten residues each. Within the ARCIMBOLDO_LITE pipeline (Sammito et al., 2015) , Phaser MR (McCoy et al., 2007) found a solution from two fragments with LLGs of 57 and 185, respectively, and Z-scores of 9.3 and 15.6, respectively, within 30 min using a IntelCore i7 3.6 GHz CPU. The model then was extended to 51 amino acids consisting of three connected helices using SHELXE (Usó n & Sheldrick, 2018) as part of the ARCIM-BOLDO pipeline (Fig. 1a ). The polyalanine model from ARCIMBOLDO was used for MR in Phaser (McCoy et al., 2007) , and the density was improved with Parrot (Cowtan, 2010) to yield improved electron-density maps. An initial sequence was postulated based on the electron density. A sequence search against the SSGCID targets revealed that the sequence matched the C-terminal region of the intended target (MysmA.00200.a). The model was built with ARP/ wARP (Langer et al., 2008) using the correct sequence. The final model was refined with PHENIX and spans ordered residues Asp240-Ala290 of the 294-amino-acid protein (Fig. 1b) . Thus, the crystals contain approximately 6 kDa protein and 61% solvent content, with a Matthews coefficient of 3.1 Å 3 Da À1 , which yields large solvent channels (Fig. 1c) . Several proteolysis sites could result in this 6 kDa fragment. For example, 3C protease was used to remove the N-terminal affinity tag, and aberrant cleavage could have occurred at residue Gln237. Alternatively, cleavage could have occurred at Arg238 by the trypsin-like protease II of E. coli (Strongin et al., 1979) if this protease were retained in tiny amounts after purification.
Although the asymmetric unit only contains one copy of the proteolytic fragment, the protein crystallized as a dimer via crystallographic symmetry. In fact, the C-terminal domain dimerized in a similar fashion to other mycobacterial MeaBand MMAA-like GTPases (Fig. 2) . N-terminal to the first ordered residue of the dimerization domain is a short linker at residue Arg238 followed by the last -helix of the GTPase domain, via analogy to other family members. As described above, Gln237 and Arg238 are possible proteolytic sites for the fragment crystallized here. The C-terminal dimerization domain of MysmA.00200.a contains different length -helices to those of the related proteins MysmA.00200.b (MSMEG_3160 gene) and MytuD.00200.a (Mtb Rv1496), reflecting their low sequence identity (<20%). As a result, the C r.m.s.d. values for these protein domains are >5 Å . Using the PDBeFOLD secondary-structure matching server (Krissinel & Henrick, 2004) 2013). Thus, it is not surprising that the structure obtained here crystallized as a dimer.
Analysis using the PSIPRED server (Buchan et al., 2013; McGuffin et al., 2000) revealed that the C-terminal domain of MysmA.00200.a should contain three helices spanning residues Pro242-Arg262, Leu267-Ala275 and Ala28-Phe289. The annotated PDB entry of this structure contains three helices spanning residues Thr241-Asn263, Asp266-Asp276 and Asp280-Leu288, which closely mirror those predicted by PSIPRED. To better understand the performance of ARCIMBOLDO, we performed a retrospective analysis in which we ran additional searches with (i) one 22-residue helix, (ii) three ten-residue helices and (iii) one ten-residue helix. All three searches yielded virtually identical models with 50-51 residues and C r.m.s.d. values between 0.4 and 0.6 Å , in which most of the difference can be attributed to the orientation of the C-terminal residue. In an additional retrospective analysis, the same set of searches was performed with Fragon (Jenkins, 2018) , which uses a similar approach to ARCIMBOLDO with a different set of programs. Fragon uses Phaser (McCoy et al., 2007) to place idealized secondary-structure elements; phases are then improved using ACORN (Yao et al., 2006) , followed by model building with ARP/wARP (Langer et al., 2008) . Searches starting from one, two and three ten-residue helices each yielded a complete model.
Conclusions
Despite not knowing exactly what was present in our 1.6 Å resolution data set, we determined the structure of a proteolytic fragment of the C-terminal dimerization domain of the intended M. smegmatis target using the ab initio structuredetermination program ARCIMBOLDO. This example serves as a robust test case for individuals interested in learning to use ARCIMBOLDO or complementary software such as Fragon. Figure 2 (a) Crystal structure of the C-terminal dimerization domain of the M. smegmatis protein from the MSMEG_4869 gene, showing the biologically relevant dimer. The asymmetric unit contains a single chain (shown in green ribbons); the second protomer of the dimer (magenta ribbons) is generated via crystallographic symmetry. (b) Crystal structure of the ortholog from M. thermoresistibile (PDB entry 3tk1), which contained a dimer in the asymmetric unit. The GTPase domains are shown as gray ribbons with GDP shown in stick representation. The dimerization domain is shown with one molecule in green ribbons and the other molecule in magenta ribbons.
